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SUMMARY
 
Decalcification is routinely performed for histological studies of bone-con-
taining tissue. Although DNA in situ hybridization (ISH) and comparative genomic hybrid-
ization (CGH) have been successfully employed on archival material, little has been re-
ported on the use of these techniques on archival decalcified bony material. In this study
we compared the effects of two commonly used decalcifiers, i.e., one proprietary, acid-
based agent (RDO) and one chelating agent (EDTA), in relation to subsequent DNA ISH and
CGH to bony tissues (two normal vertebrae, six prostate tumor bone metastases with one
sample decalcified by both EDTA and RDO). We found that RDO-decalcified tissue was not
suited for DNA ISH in tissue sections with centromere-specific probes, whereas we were
able to adequately determine the chromosomal status of EDTA-decalcified material of both
control and tumor material. Gel electrophoresis revealed that no DNA could be successfully
retrieved from RDO-treated material. Moreover, in contrast to RDO-decalcified tumor ma-
terial, we detected several chromosomal imbalances in the EDTA-decalcified tumor tissue
by CGH analysis. Furthermore, it was possible to determine the DNA ploidy status of EDTA-
but not of RDO-decalcified material by DNA flow cytometry. Decalcification of bony sam-
ples by EDTA is highly recommended for application in DNA ISH and CGH techniques.
 
(J Histochem Cytochem 47:703–709, 1999)
 
B
 
one and bone-containing specimens
 
 are inher-
ently difficult tissues to work with histologically. Prob-
lems arise in cutting sections of bone marrow biopsy
specimens, bone tumor samples, or biopsies of me-
tastases to the bone because of the intimate mixture of
hard tissue (bone) and soft tissue (marrow, fat, or neo-
plastic tissue). To cut adequate intact sections, one can
either make the tissue uniformly hard by freezing of
fresh material or by embedding in plastic, or one can
make the tissue uniformly soft by decalcification fol-
lowed by paraffin embedding. Although cryostat sec-
tioning allows optimal antigen preservation, this method
has not gained widespread acceptance because the poor
morphological preservation severely hampers histolog-
ical evaluation. In contrast, plastic embedding results
in tissue sections with excellent cell morphology. How-
ever, major disadvantages are the laborious procedure
and the frequent loss of immunoreactivity. Moreover,
plastic-embedded material appears less suited for
DNA or mRNA in situ hybridization (ISH) techniques
(Cao and Beckstead 1989). To obtain satisfactory par-
affin sections of bone-containing samples, it is neces-
sary to soften the tissue by removing the mineral. This
is carried out by treatment with reagents that react
with calcium: acids to form soluble calcium salts or
chelating agents to take up calcium ions. Strong acids,
e.g., nitric and hydrochloric acid, as well as many hy-
drochloric acid-containing proprietary decalcifiers (e.g.,
RDO), decalcify rapidly, but if they are used for longer
periods serious deterioration of stainability, especially
of nuclear chromatin, can occur (reviewed in Stevens
et al. 1990; Callis and Sterchi 1998). Using chelating
agents for decalcification, such as EDTA (ethylenedi-
aminetetra-acetic acid), might circumvent this prob-
lem. Decalcification in EDTA has little or no effect on
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tissues other than the bone mineral itself. However,
the major disadvantage is that decalcification by EDTA
proceeds only slowly, with incubation times up to sev-
eral weeks depending on the extent of mineralization
(Stevens et al. 1990). Recently, successful nonisotopic
mRNA ISH was reported on EDTA-decalcified bony
tissue, and less or even no reactivity was found when
samples were decalcified by strong acids (e.g., HCl,
formic acid; Arber et al. 1997; Kabasawa et al. 1998).
Interphase ISH applied to archival tissue sections
with centromeric or region-specific probes (e.g., onco-
gene-specific) has been established as a useful tech-
nique for recognition of chromosomal alterations in a
histological background (reviewed by Alers and van
Dekken 1996; Jenkins et al. 1997; van Dekken et al.
1997). More recently, comparative genomic hybrid-
ization (CGH) has been introduced as a new technique
for global analysis of the entire genome for loss or
gain of chromosomal regions. One of the main advan-
tages of CGH is that it can be performed on archival
material (Isola et al. 1994). At present, genetic data on
tumors in bone, e.g., osteosarcomas, as assessed by
molecular genetic and ISH techniques, have been ob-
tained by using fresh material or soft tissue but not de-
calcified archival material (e.g., McManus et al. 1995;
Tarkkanen et al. 1995,1996).
Our laboratory is interested in the identification of
genetic events that underlie metastasis of prostate can-
cer to bone. Recurrent failure of the interphase ISH
applied to bone metastases prompted the question of
whether the routine decalcification of bone-containing
samples could interfere with ISH techniques. There-
fore, we compared the effect of two different decalcifi-
cation agents, i.e., RDO vs EDTA, on the quality of ISH
and CGH applied to formalin-fixed, paraffin-embed-
ded specimens of bony tissues.
 
Materials and Methods
 
Tissue Specimens
 
Our panel consisted of five archival, routinely RDO-decalci-
fied bone metastases of prostate adenocarcinoma (three bi-
opsy specimens and two derived from autopsy). To compare
different decalcification methods, we selected osseous mate-
rial, derived from autopsy, of the vertebral column of three
more patients, one bone metastasis of prostate adenocarci-
noma to the lumbar spine and two normal control cases (one
male, one female). Autopsy was performed between 8 and
24 hr after death. These tissue specimens were routinely
fixed in buffered formalin and subsequently divided into
halves. One half of each vertebra was decalcified according
to a routine protocol; the other half was decalcified accord-
ing to an experimental procedure.
 
Decalcification
 
Two different methods of decalcification were used. At our
department, decalcification of bone-containing material is
 
routinely performed using RDO, a multipurpose decalcifier
(Apex Engineering Products; Plainfield, IL). The active ingre-
dient in RDO is hydrochloric acid. RDO stock solution was
diluted 1:1 in distilled water. Decalcification in RDO was
routinely performed for a period of 6–16 hr at room temper-
ature (RT).
The other vertebral halves were decalcified using the
chelating agent EDTA. We used a 10% EDTA solution in
distilled water, pH 7.4, for a period of 2–3 weeks at 4C, de-
pending on degree of mineralization, with renewal of EDTA
every week. After decalcification, samples were routinely
processed and embedded in paraffin.
 
DNA In Situ Hybridization (ISH)
 
ISH with a biotin-labeled DNA probe set specific for chro-
mosomes 1, 6, 7, 8, and Y was performed as described by
van Dekken et al. (1992). Briefly, to facilitate DNA probe
accessibility to the cellular DNA, sections were digested with
0.4% pepsin (Sigma; St Louis, MO) in 0.2 M HCl at 37C for
5–60 min. Cellular DNA was heat-denatured for 2 min in
70% formamide in 2 
 
3
 
 SSC (pH 7.0) at 72C. The chromo-
some-specific repetitive DNA probes were denatured for 10
min at 72C in a hybridization mixture containing 2 
 
m
 
g/ml
probe DNA, 500 
 
m
 
g/ml sonicated herring sperm DNA
(Sigma), 0.1% Tween-20, 10% dextran sulfate, and 60%
formamide in 2 
 
3
 
 SSC at pH 7.0. The slides were then incu-
bated overnight at 37C in a moist chamber and subsequently
washed. Histochemical detection of the biotinylated DNA
probes was performed by the standard avidin–biotin com-
plex (ABC) procedure and immunoperoxidase staining. Sec-
tions were counterstained with hematoxylin.
 
Evaluation of ISH Results
 
The DNA probe set was analyzed for each sample on con-
secutive 4-
 
m
 
m sections in a previously defined area. A sec-
tion size of 4 
 
m
 
m was chosen after evaluating the degree of
nuclear overlap (
 
5
 
 countability) and section thickness. For
each of the probes, 100 “intact” (
 
5
 
 spherical) and nonover-
lapping 4-
 
m
 
m nuclear slices were counted by two indepen-
dent investigators (100 nuclei each) and the number of solid
diaminobenzidine (DAB) spots per nuclear fragment was
scored (0, 1, 2, 3, 4, 
 
.
 
4 spots per nuclear slice). The individ-
ual DNA probe spot distributions were then compared and
totaled when no significant counting differences between the
investigators were found. In our experiments, no discrepan-
cies emerged using this approach. The probe spot distribu-
tions were statistically evaluated by the Kolmogorov–Smirnov
test. Overrepresentation of a specific chromosome was seen
as a shift to the right of the DNA probe distribution com-
pared with nonaberrant probe distributions. This method is
described in detail in previous studies (Alers and van Dekken
1996; Alers et al. 1997).
 
Comparative Genomic Hybridization (CGH)
 
Isolation of DNA from the formalin-fixed, decalcified, par-
affin-embedded normal and tumor material was performed
as described by Alers et al. (1997). Briefly, the same tissue
blocks used for ISH analysis were counterstained in 4,6-dia-
midino-2-phenyl indole (DAPI; 0.1 
 
m
 
g/ml in distilled water)
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for 5 min and placed under a fluorescence microscope, en-
abling precise selection of the (tumor) area. Microdissection
of the (tumor) areas was performed using a hollow bore cou-
pled to the microscope. Lower boundaries were checked for
the presence of tumor on hematoxylin–eosin-stained tissue
sections. Excised material was minced using a fine scalpel,
deparaffinized in xylene and ethanol series, and dried. Sam-
ples were digested in 1 ml of extraction buffer (10 mM Tris-
HCl (pH 8.0), 100 mM NaCl, 25 mM EDTA, 0.5% SDS,
and 300 
 
m
 
g/ml proteinase K) and incubated at 55C for 3–4
days (Isola et al. 1994). Fresh proteinase K (300 
 
m
 
g/ml) was
added every 24 hr. Samples were treated with RNase (1:25
of 10 mg/ml) for 1 hr at 37C. DNA was isolated according
to standard protocols using phenol:chloroform extraction at
least four times, followed by chloroform twice. Concentra-
tion, purity, and molecular weight of the DNA were estimated
using both a fluorometer (DyNA Quant 200; Hoefer Bio-
tech, San Francisco, CA), UV spectrophotometry (Genequant;
Pharmacia Biotech, Uppsala, Sweden), and ethidium bromide-
stained agarose gels with control DNA series.
Tumor DNA was labeled with biotin by nick-translation
(Nick Translation System; Gibco BRL, Gaithersburg, MD).
Likewise, male reference DNA (Promega; Madison, WI) was
labeled with digoxigenin (Boehringer Mannheim; Indianapo-
lis, IN) by nick-translation. The reaction time and the
amount of DNAse were adjusted to obtain a matching probe
size for reference DNA and tumor DNA. Molecular weight
of both tumor and reference DNA was checked by gel elec-
trophoresis. Probe sizes were between 300 and 1.5 
 
kb
 
.
CGH was performed essentially according to the proce-
dure described by Kallioniemi et al. (1992). In brief, normal
male metaphase chromosomes were denatured, dehydrated,
and air-dried; 200 ng of each labeled tumor DNA and refer-
ence DNA and 15 
 
m
 
g of unlabeled Cot-1 DNA were etha-
nol-precipitated and dissolved in 10 
 
m
 
l of hybridization mix-
ture (50% formamide, 0.1% Tween-20, and 10% dextran
sulfate in 2 
 
3
 
 SSC, pH 7.0). The probe mixture was dena-
tured and hybridized to normal metaphase chromosomes.
After washing of the slides, fluorescent detection of the bi-
otin- and digoxigenin-labeled DNA probes was accom-
plished with avidin–fluorescein isothiocyanate and anti-
digoxigenin rhodamine, respectively, for 1 hr at 37C. Sam-
ples were counterstained with DAPI in antifade solution.
For image acquisition, an epifluorescent microscope
(Leica DM; Rijswijk, The Netherlands) equipped with a
cooled CCD camera (Photometrics; Tucson, AZ) and a triple
bandpass beam splitter and emission filters (P-1 filter set;
Chroma Technology, Brattleboro, VT) was used. Gray level
images of each of the three fluorochromes were collected
and a three-color image was built up by overlay of the three
images in pseudo-colors selected to match the original color
of the fluorochromes, using an algorithm implemented in
SCIL image (TNO; Delft, The Netherlands) on a Power
Macintosh 8100. Image analysis was performed with the use
of QUIPS XL software (version 2.0.3; Vysis, Downers
Grove, IL), using reversed DAPI banding to identify the
chromosomes. Loss of DNA sequences was defined as chro-
mosomal regions in which the mean green:red ratio is below
0.8, and gain was defined as chromosomal regions in which
the ratio was above 1.2. These threshold values were based
on series of normal controls.
 
DNA Flow Cytometry
 
DNA content of the paraffin material was measured as de-
scribed by Hedley et al. (1983). Three to five 50-
 
m
 
m slices of
the three vertebrae were selectively cut out of the paraffin
blocks. Flow cytometry and analysis of the ethidium bro-
mide (Sigma)-stained nuclei from these areas was performed
using a Facscan (Becton Dickinson; Mountain View, CA).
Tissue from a normal lymph node served as a diploid con-
trol. A DNA index between 0.8 and 1.2 was considered dip-
loid.
 
Results
 
Histology and DNA Flow Cytometry (FCM)
 
Routinely processed hematoxylin and eosin (H&E)
sections of the three archival bone specimens appeared
to show a better histology and more detail in the
EDTA-decalcified tissues than in the RDO-treated
samples (Figures 1A, 1C, 1E, and 1F).
DNA FCM of RDO-decalcified samples of the two
normal vertebrae revealed mainly nuclear debris; no
DNA index (DI) could be determined. However, DNA
FCM of the EDTA-treated specimens displayed a dip-
loid profile in both samples (DI 0.8 in both cases).
DNA FCM of the RDO-decalcified archival prostate
tumor metastases to the bone rendered only nuclear
debris (Figure 1G), whereas the EDTA-decalcified ma-
terial showed a distinct diploid and a tetraploid peak
(DI 
 
5
 
 2.1; percentage non-2C peak 
 
5
 
 15%; Figure
1H). The coefficient of variation (CV) values of the
EDTA-treated samples were comparable to those of un-
decalcified, paraffin-embedded material derived from
autopsy.
 
In Situ Hybridization (ISH)
 
The failure to detect any signals with interphase ISH
in five routinely RDO-decalcified bony tumor me-
tastases (data not shown), whereas non-osseous me-
tastases in the same experiments showed excellent
ISH, prompted us to investigate the effects of decalcifi-
cation on interphase ISH. ISH with the chromosome
1-specific DNA probe to paraffin-embedded tissue
sections of the RDO-decalcified parts of both the nor-
mal bone marrow samples, as well as the prostate tu-
mor metastases, failed to detect ISH signals (Figures
1B and 1I). Even prolonged pepsin digestion incuba-
tion times, as well as higher pepsin concentrations, did
not render any improvement. Moreover, after the ISH
procedure the tissue showed a fuzzy appearance, with
overflowing of the nuclei (Figures 1B and 1I). ISH
with the probes specific for chromosomes 1, 6, 7, 8,
and Y to the EDTA-decalcified normal bone speci-
mens revealed strong hybridization signals for all
probes (Figure 1D) with normal (diploid) distribution
patterns.
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ISH with the same probe set applied to the prostate
tumor metastases distinguished overrepresentation of
chromosome 8 compared to the other autosomal probes
(Figures 1J and 1K). Furthermore, the sample was
slightly hyperdiploid, with 11% of the nuclei showing
more than two hybridization dots for the other nonab-
errant probes.
 
Comparative Genomic Hybridization (CGH)
 
DNA was isolated from eight RDO- and three EDTA-
decalcified archival (tumor) samples. No DNA could
be retrieved from the RDO-decalcified samples, whereas
DNA ranging in sizes up to 10 
 
kb
 
 could be extracted
from both normal and tumor EDTA-treated materials.
The latter is exemplified by Figure 2A, showing DNA
from an EDTA- and an RDO-decalcified tumor sam-
ple in Lanes 2 and 3, respectively. Gel electrophoresis
of the other samples showed a similar pattern, with no
detectable DNA isolated from the RDO-treated mate-
rial and a DNA smear comparable to Lane 2 for the
two normal EDTA-decalcified samples (bulk DNA frag-
ment size around 400 
 
bp
 
). Subsequent CGH of the tu-
mor sample showed loss and gain of several sequences
(Figure 2B). Loss was seen on chromosome regions
5q12–q22, 6q16–q21, 8p12–p21, 10q21–q24 (inter-
pretation). Gain was found of 7p15–pter, 7q32–q33
and 8q11.2–qter sequences. Furthermore, the combi-
nation of 8p loss and 8q gain, together with the over-
representation of the centromeric region of chromo-
some 8, as detected by ISH (Figures 1J and 1K) is
suggestive for isochromosome formation of 8q. In ad-
dition, loss of 10q, found by CGH, was confirmed by
loss of heterozygosity (LOH) study, illustrating the
suitability of the EDTA decalcification method for in
vitro DNA studies (Figure 2C).
 
Figure 1
 
Comparison of the effect of decalcification of bony material by RDO (left) or EDTA (right) on DNA in situ hybridization (ISH) and
DNA flow cytometry (FCM). The ISH-related signals were visualized with immunoperoxidase–DAB (black); Mayer’s hematoxylin was used as
a counterstain. (
 
A,B
 
) Hematoxylin and eosin (H&E)-stained tissue section of RDO-decalcified normal bone marrow (
 
A
 
). Corresponding ISH
with the chromosome 1-specific probe. No ISH signals were seen in the nuclei (
 
B
 
). (
 
C,D
 
) H&E section of the EDTA-decalcified part of the same
bone marrow (
 
C
 
). The general morphology of the cells is much better compared to 
 
A
 
, even at low magnification. Corresponding ISH with a
probe specific for chromosome 1 shows strong ISH signals in the nuclei. A normal diploid spot distribution for ISH to 4-
 
m
 
m tissue sections
with an autosomal probe is seen, with most nuclei displaying two spots (
 
D
 
). (
 
E,F
 
) H&E section of a bone metastasis of prostate adenocarci-
noma, decalcified with RDO (
 
E
 
). The morphology of both tumor cells (arrows) and osteocytes in the bone trabeculae (arrowheads) is much
better appreciated when decalcified with EDTA (
 
F
 
). (
 
G,H
 
) DNA flow cytometry (FCM) of the prostatic tumor bone metastasis. DNA FCM of
RDO-decalcified material showed only nuclear debris (
 
G
 
), whereas in the EDTA-decalcified specimen both a diploid and a tetraploid peak
could be distinguished (
 
H
 
). (
 
I–K
 
) ISH with the chromosome 1-specific probe to RDO-decalcified material of the same metastasis. No ISH-re-
lated signals could be visualized in the nuclei (
 
I
 
), whereas in the EDTA-decalcified material ISH signals were easily identified in both tumor
cells (arrows) and osteocytes (arrowhead, 
 
J
 
). Moreover, ISH with the chromosome 8-specific probe to the same area detected gain of chro-
mosome 8, visible as many nuclei with three or more spots (arrows). The osteocytes show a normal diploid pattern (arrowhead, 
 
K
 
). Bars:
 
A,C,E,F
 
 
 
5
 
 50 
 
m
 
m; 
 
B,D
 
 
 
5
 
 25 
 
m
 
m; 
 
I–K
 
 
 
5
 
 10 
 
m
 
m.
Figure 2 (A) Ethidium bromide-
stained agarose gel. Lane 1, 250-BP
DNA ladder. The 1-KB band is marked.
Lane 2, DNA isolated from EDTA-
decalcified material of an archival
prostate tumor metastasis to the
bone. The DNA smear is characteristic
for routinely formalin-fixed, paraffin-
embedded material. Lane 3, DNA iso-
lation of RDO-decalcified material of
the same case rendered no detectable
DNA. (B) Comparative genomic hy-
bridization (CGH) of the archival pros-
tate tumor metastasis to the bone us-
ing the same DNA. The chromosomal
ideograms are shown along with the
mean ratio profiles of chromosomes
3, 5, 6, 7, 8, and 10 (number of chro-
mosomes analyzed is seven or eight,
lower/upper thresholds at ratios 0.8/1.2). Telomere ends are excluded from CGH analysis. Deleted regions are displayed as a black bar at left
of the ideogram; gains are depicted along the right side. Loss was seen of 5q12–q22, 6q16–q21, 8p12–p21, 10q21–q24 (interpretation); gain
was detected of 7p15–pter, 7q32–q33, and 8q11.2–qter sequences. An example of a chromosome without inbalances is shown by the nor-
mal ratio profile for chromosome 3. (C) PCR-mediated loss of heterozygosity (LOH) analysis of the EDTA-decalcified bone metastasis, using a
microsatellite marker D10S2491 (PTEN CA repeat) located in the 10q23 region. Loss of the upper allele (arrowhead) is seen in the tumor (T)
compared to the normal tissue (N).
 708
 
Alers, Krijtenburg, Vissers, van Dekken
 
Discussion
 
The aim of this study was to compare the effect of two
different decalcification agents, i.e., RDO and EDTA,
on the quality of interphase in situ hybridization (ISH)
and comparative genomic hybridization (CGH), applied
to formalin-fixed, paraffin-embedded tissue of bone-
containing samples. The results unequivocally show
that routinely processed RDO-decalcified tissue is not
suitable for DNA-involving techniques, like DNA ISH
and CGH. In addition, the utility of DNA FCM ap-
peared notably reduced. This is in marked contrast to
EDTA-decalcified tissues, in which we were able to de-
termine the ploidy status of all bony samples and to
demonstrate the presence of gain of chromosome 8 in
a prostate osseous metastasis by interphase ISH. More-
over, CGH analysis of the same sample showed loss
and gain of several sequences, most importantly con-
comitant loss of 8p and gain of 8q. The latter combi-
nation is suggestive of an i(8q) formation, a chromo-
somal abnormality that may be related to prostate tumor
metastasis to the bone (Alers et al. 1997). In addition,
loss found by CGH was confirmed by LOH analysis.
This indicates that, after EDTA-decalcification, the
samples are also suitable for PCR analysis. Our data
are in concordance with other (limited) data on pros-
tate tumor metastases using ISH and CGH techniques
(Cher et al. 1996; Jenkins et al. 1997).
Prolonged treatment of tissue with strong acids,
such as in RDO, apparently causes acid hydrolysis of
DNA. Completely degraded DNA in nuclei of RDO-
decalcified tissue would explain the absence of fluo-
rescence in DNA FCM, as well as the inability to per-
form successful ISH with DNA-specific probes. This is
supported by the fact that it was not possible to isolate
DNA from RDO-decalcified bony tissue specimens.
Hydrolysis of DNA is circumvented by decalcification
in EDTA, because this procedure is performed at near
neutral pH. Our findings are in agreement with lim-
ited data reported by others. For example, Arber and
co-workers (1997) compared three commercially avail-
able decalcifying agents, including one EDTA-based
solution (Versenate) and two hydrochloric acid-based
solutions (S/P Decal, RBD). The agents were tested for
mRNA ISH using a biotinylated poly d(T)oligonucle-
otide probe in paraffin-embedded tissue sections of
(non)-neoplastic specimens. Versenate showed gener-
ally excellent reactivity compared to undecalcified
controls, but less reactivity was seen with S/P Decal
and especially with RBD. Similar findings were ob-
served by Walsh et al. (1993) in a comparison of the
effect of decalcification on mRNA ISH, using nitric
acid, formic acid, and EDTA. Furthermore, Michaels
et al. (1994) attributed the partially negative results
with DNA ISH for cytomegalovirus in temporal bones
of patients with AIDS to prolonged decalcification in
formic acid. Moreover, fluorescent ISH with a chro-
mosome 8-specific probe applied to bone marrow bi-
opsy samples that were rapidly decalcified in another
acid agent, Carbag solution, was unsuccessful in 40%
of cases (Miranda et al. 1994). In contrast, several
groups reported successful nonisotopic mRNA expres-
sion in paraffin sections of EDTA-decalcified rat bones
(e.g., Hirakawa et al. 1994; Kabasawa et al. 1998).
At present, the application of EDTA as a decalcify-
ing agent in a routine setting is hampered by the long
time required for incubation. However, new methods,
such as decalcification in EDTA using a microwave
oven (Hellström and Nilsson 1992), addition of am-
monium hydroxide to the EDTA solution (Sanderson
et al. 1995), electrolytic decalcification (Loyson et al.
1997), or a one-step fixation–decalcification in Lowy
formalin mercuric chloric acid solution, which also
appears suitable for mRNA ISH (Gaulier et al. 1994),
might reduce the time of decalcification considerably.
Moreover, antigenic sites, DNA, and mRNA are pre-
served. Recent developments in plastic technology, es-
pecially the introduction of new resins that can be re-
moved after sectioning, as well as new methods for
antigen retrieval, indicate that DNA and mRNA ISH
on plastic-embedded tissue will become more feasible
in the near future (McCluggage et al. 1995; Church et
al. 1997; Warren et al. 1998).
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